Tom Wilemon Archive
-
September 29, 2020
VICC receives ‘exceptional’ score with renewal as an NCI-Designated Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center (VICC) received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute (NCI) and places it once again in a top group of NCI Comprehensive Cancer Centers. -
September 24, 2020
VICC leading first global study of MDS/MPN overlap syndrome
Overlap syndromes are distinct blood cancers that present with features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). -
September 17, 2020
Chic Awearness Sept. 24 virtual event to focus on ovarian cancer research
Chic Awearness, in collaboration with the Vanderbilt-Ingram Cancer Center, will host a virtual event on Sept. 24 focusing on ovarian cancer research and its impact during COVID-19. -
August 27, 2020
Vanderbilt-Ingram opens cancer center in Wilson County
Vanderbilt-Ingram Cancer Center at Wilson County is slated to open Aug. 31 with a full array of highly specialized services, including diagnostic assessments, medical oncology and radiation oncology. -
August 26, 2020
Chang named Vanderbilt-Ingram Cancer Center chief surgical officer
Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties. -
August 13, 2020
Newer targeted therapy prolongs life for lung cancer patients
Patients with ALK-positive non-small cell lung cancer treated with ensartinib fared better and lived longer than those who received crizotinib, according to results of a phase 3 study.